Anticoagulation Therapy Management for Pharmacists

Program Details

  • Intended Audience: Pharmacists who treat patients with diseases and disorders requiring anticoagulation therapy or pharmacists interested in learning more about anticoagulation therapy.
  • UAN: 0012-0000-16-455-H01-P
  • CE Hours: 40.5
  • Price: $795.00
  • Dates Available: 10/10/2016 to 10/10/2019*
  • Activity Type: Practice

*All coursework must be complete by 10/10/2019 at 11:59 pm (ET)

Enroll Now


This course is intended for pharmacists who manage or who plan to manage patients who have diseases and disorders requiring anticoagulation therapy. The major course objective is for pharmacists to achieve a high level of confidence with patients who require anticoagulation and with their primary care physician.  This confidence is the result of a greater depth of understanding the patient’s disease state, the therapy used and the monitoring parameters for patients receiving anticoagulation agents.


Course Objectives

  • Relate how pharmacokinetics and pharmacodymanics principles are used to achieve and maintain anticoagulation control within the patient’s therapy goals.
  • Describe the complexities of managing drug therapy and other treatment modalities.
  • Summarize how pharmaceutical care is applied for patients requiring anticoagulation therapy.
  • Use effective interpersonal skills to better educate patients, caregivers, and other healthcare professionals regarding safe and optimal anticoagulation therapy.
  • Design an anticoagulation management service for effective patient care.
  • Document anticoagulation therapy for patients receiving such therapy.

Module 1: Updates in Outpatient Anticoagulation Management: An Overview

  • Describe how clotting occurs and the morbidity associated with clots
  • Review the clotting cascade and how pharmacotherapy targets this process
  • Explain pertinent pharmacokinetic, drug/drug and drug/food interactions that can occur with patients on vitamin-K antagonists
  • Review basic pathophysiology and appropriate treatment options for patients requiring anticoagulation treatment for the following conditions
    1. Atrial fibrillation
    2. Valve disorders
  • State how a pharmacist can identify, assess and solve medication-related problems for patients on anticoagulation therapy

Module 2: Inpatient Anticoagulation Therapy

  • Identify and assess risk factors, indications, and other applicable considerations to initiate, transition, or modify anticoagulant therapy for inpatients
  • Review and evaluate the options for anticoagulation therapy for different inpatient populations, goals of therapy, and co-morbidities
  • Apply clinical, safety, and financial considerations to:
    1. Select the most appropriate agent,
    2. Develop the patients’ anticoagulation therapy plan
    3. Monitor and evaluate safety and efficacy parameters for therapy, and
    4.Make recommendations to modify and/or optimize the anticoagulation therapy to achieve the desired outcomes
  • Evaluate and modify anticoagulant therapy in preparation for the transition of the patient’s care to home or a different level of care, based on patient-specific risk factors, adherence to therapy, and requirement for follow up
  • Provide patient education with the goal to optimize therapy and prevent the risk of adverse medication events associated with anticoagulant therapy

Module 3: Anticoagulation Management of DVT and PE

  • List the risk factors for developing a DVT and/or PE
  • Identify the signs and symptoms of a DVT and PE
  • Discuss duration of treatment based on the type of DVT and PE and other risk factors
  • Discuss non-pharmacological therapies, and when not to recommend anticoagulation therapy.
  • Discuss the pharmacological treatments for DVT and PE
  • Complete a case study involving a DVT or PE

Module 4: Peri-Procedural

  • Describe the clinical conundrum when anticoagulation therapy needs to be interrupted
  • Review CHEST Guideline recommendations regarding periprocedural management and compare and contrast more recent periprocedural literature
  • Explain the decision-making process when developing a patient-specific plan for patients on anticoagulants undergoing procedure
  • Elective versus urgent procedures
  • Low-risk versus high-risk bleeding procedures

Module 5: Complication with Anticoagulation

  • Recognize complications of antithrombotic therapy
  • Review the recommendations and options to manage complications associated with anticoagulants, including the reversal of antithrombotic effect
  • Develop a treatment plan to manage complications associated with antithrombotic therapy

Module 6: Medication Therapy Management

  • Evaluate the need of medication therapy management services within the scope of an anticoagulation clinic.
  • Understand the core components of medication therapy management.
  • Explain the rationale and benefits of utilizing medication therapy management in an inpatient, outpatient or consultant role in anticoagulation monitoring.
  • Understand and discuss the cost, staffing and management of performing MTM services to patient’s in anticoagulation clinics.
  • Explore the billing mechanisms that could be used to be reimbursed for MTM services in anticoagulation clinic settings.
  • Review methods such as motivational interviewing that can be used to gain knowledge about patient’s understanding of the importance of anticoagulation therapy.
  • Define the parameters that could be used to access the efficiency and return on investment, including quality parameters to access medication therapy management and it’s importance to anticoagulation clinic patients.
  • Incorporate patient interviewing and teaching skills into medication therapy management sessions to support, educate and encourage behaviors meeting current recommended guidelines for patient’s on anticoagulation therapy

Acknowledgements and Disclosures

The following speakers, reviewers, and planning committee members have disclosed that he/she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.

Jessica J. Edwards Lucas, Pharm. D., BCACP
Clinical Pharmacy Specialist
Malcom Randall VA Merical Center

Joseph J. Fierro, Pharm. D., BCACP
Clinical Pharmacy Specialist in Ambulatory Care/Specialty Clinics
Program Director, Pharmacy Residency Program
James A. Haley Veterans Hospital

Abby Rivas Marrero, Pharm.D., BCPS, BCCP
Clinical Pharmacy Manager
West Kendall Baptist Hospital

Schedule of Activities

  • Complete all six modules (ie. view all six recorded lectures and read the supplemental materials)
  • Submit the required module assignments
  • Receive 80% or higher on all six module quizzes
  • Complete an online program evaluation
  • All coursework must be complete by 10/10/2019 at 11:59 pm (ET)  

Requirements for Successful Course Completion

Review the course material, receive a 80% or higher on all 6 module post-tests, and complete an online program evaluation.

Credit Reporting

  • The University of Florida College of Pharmacy will report CPE credit to CPE Monitor and CE Broker when applicable. If you would like a paper statement of credit, you may print it from your NABP e-profile.
  • All pharmacists and pharmacy technicians maintain their own license and/or certification and it is their responsibility to follow up with the Office of Continuing Education at the University of Florida if any CE credit discrepancies are found.
  • It is at the University’s discretion to award or deny credit to a late claiming participant (i.e. after 60 days of the participant engaging in a CPE activity) as it is the University’s CE activity and the provider needs to ensure the requirements necessary for credit are successfully completed.
  • The University may request access to CPE Monitor® if the activity in question occurred within the previous 6 months and with an appropriate reason for access, i.e. power outage, etc.

Program Financial Support

This course received no outside funding support.

Computer Requirements

Computer and Internet access are required to complete this course. Course content is provided via Canvas.

The minimum hardware, software, and Internet requirements for Canvas can be found here.


Refund Policy for CE Courses

Privacy and Confidentiality Policy


This course in its entirety is copyrighted by the University of Florida Continuing Pharmacy Education and may not be duplicated or reproduced for any other purpose without specific written permission.

For questions or more information, please contact our office.

ACPE logo

The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.